Ko, M.M.; Jeong, M.-K.; Choi, C.M.; Lee, S.H.; Chun, J.; Yi, J.-M.; Jang, H.; Lee, S.Y.
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial. Int. J. Environ. Res. Public Health 2023, 20, 4507.
https://doi.org/10.3390/ijerph20054507
AMA Style
Ko MM, Jeong M-K, Choi CM, Lee SH, Chun J, Yi J-M, Jang H, Lee SY.
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial. International Journal of Environmental Research and Public Health. 2023; 20(5):4507.
https://doi.org/10.3390/ijerph20054507
Chicago/Turabian Style
Ko, Mi Mi, Mi-Kyung Jeong, Chang Min Choi, Seung Hyeun Lee, Jaemoo Chun, Jin-Mu Yi, Ho Jang, and Sung Yong Lee.
2023. "Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial" International Journal of Environmental Research and Public Health 20, no. 5: 4507.
https://doi.org/10.3390/ijerph20054507
APA Style
Ko, M. M., Jeong, M.-K., Choi, C. M., Lee, S. H., Chun, J., Yi, J.-M., Jang, H., & Lee, S. Y.
(2023). Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial. International Journal of Environmental Research and Public Health, 20(5), 4507.
https://doi.org/10.3390/ijerph20054507
